Company intelligence / Profile preview

Ginolis

Oulunsalo, Finland

Ownership: Private
Employees: ~65
Development stage: Other

Overview

Ginolis is a precision automation and microfluidics manufacturing company providing automation solutions for diagnostic and medical device manufacturing. The company transitioned to commercial production post-management buyout from BICO Group in November 2023, and in 2024, CELLINK AB announced an agreement to acquire Ginolis for €70 million.

Industry: Non-Drug Biotech

Partnerships

Probot Oy (preferred partner agreement for robotics solutions)[3]Mobidiag Ltd (manufacturing solutions for Novodiag cartridges)[5]

Beyond the preview

Go deeper on Ginolis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ginolis.

Explore the full profile